Albumin-interferon alpha 2a fusion protein (Yeast)

重组人血清白蛋白-干扰素α2a融合蛋白(酵母)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlbumin-interferon alpha 2a fusion protein (Yeast)
Drug Alias NamerHSAIFN alpha-2a
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInstitute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation ArmyQilu Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesInstitute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation ArmyInstitute Of Bioengineering, Academy Of Military Medical SciencesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A